Targeting Rare Diseases and Critical Care

Over the past 25 years, the Group has become a recognised provider of integrated therapy solutions, operating from its headquarters in Vienna, subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide. Since its inception, the company has focused on individual patient needs and treatment. With a research-driven approach, AOP Health has an in-depth knowledge of rare diseases and critical illness care. As a result, the company has been able to position itself as an innovative leader in the development of effective treatments and medicines.

Whether a disease is defined as a rare disease depends on the frequency of its occurrence in the population. However, from the global point of view the definition is not consistent. Thus, in Europe those diseases that occur in less than 5 per 10,000 residents are defined as rare diseases.